Diabetes

Testing

Centers

Reimbursable

Solutions











Medical Providers ONLY

Increase Compliance and Revenue

Evidence-Based Reductions

Welcome Providers!

Diabetes Testing Centers (DTC) was founded 15 years ago to assist private medical clinics in generating revenue through our specialized in-clinic services for diabetes and related chronic conditions. Over the years, we have expanded our offerings to provide comprehensive, turnkey solutions that streamline patient care and enhance practice revenue by integrating both in-clinic and remote services. Our in-clinic services offer multiple health risk assessments from head-to-toe, including retinopathy screenings, peripheral neuropathy, and cardiovascular risk factors. They are available on a per-test basis, as turnkey solutions, or through purchase or monthly rental options—flexibly designed to meet your clinic’s specific needs.

Outside-the-Clinic Services

Our remote services operate under a Done-For-You service model, offering fully managed programs like Chronic Care Management (CCM) and Remote Patient Monitoring (RPM). We take care of the entire process—from patient enrollment to ongoing care coordination—ensuring compliance and seamless execution with minimal staff involvement. This integrated approach improves patient outcomes, strengthens CMS compliance, and enhances operational efficiency, allowing your practice to focus on delivering high-quality care while maximizing revenue. 

Turn Unbilled Services into Revenue

Cardiovascular & Circulatory

Metabolic & Systemic

Neurological & Mental Health

Revenue-Growth Partner

DTC is the premier strategic revenue-growth partner in the U.S. for distributors and medical clinics, including the largest non-acute Group Purchasing Organization (GPO), which supports over 20,000 clinics nationwide. Through our GPO partnership, we help clinics significantly reduce costs and enhance operational efficiency. Our team of clinical, operational, and billing experts ensures accurate billing and maximizes reimbursements for eligible patient care services covered by CMS.

Saving Money is Making Money

Partnering with DTC enables clinics to reduce costs, minimize administrative burdens, and focus on delivering exceptional patient care while unlocking new revenue streams. By continuously expanding our offerings and refining processes, we empower clinics to stay ahead of industry trends and provide quality care. It’s time to unlock your revenue potential—contact us to get started.

Servicing Chronic Conditions

Health Risk Assessments

Turnkey: Use Our Staff and Our Technology

Customized Testing Services

DTC offers more than just advanced health-risk assessments—we provide a low-risk, high-reward opportunity to invest in your own success. By integrating DTC's customized diagnostics into their practices, providers are not only enhancing patient care but also significantly elevating their professional value and growth with zero down or minimal upfront investment (OAC). DTC enables clinics to seamlessly incorporate testing services into their existing offerings with ease and flexibility.

Providers can choose from a variety of non-invasive, quick, and reimbursable tests that align perfectly with their practice management. This level of customization not only improves diagnostic accuracy and patient outcomes but also opens new revenue streams through specialized, in-house diabetes testing, all while minimizing financial risk. This approach ensures that clinics can meet the unique needs of their patient populations efficiently. 

Providers, partnering with DTC is a strategic investment in the future of your practice and personalized care, all while upholding CMS compliance standards. This collaboration places you at the forefront of healthcare innovation and promises exceptional patient outcomes. It’s not just an investment in technology and services; it’s an investment in your practice, your patients, and the significant changes you can make by enhancing the standard of care.

Revenue from Day One

Click here to see more of our assessments that can impact your practice (mix and match combos).

Compliance & Revenue

Working Smarter

Comprehensive and Reimbursable

At DTC, we recognize that diabetes care is not a one-size-fits-all solution. We offer a wide range of diagnostic assessments, empowering healthcare providers to manage diabetes from early detection to the management of complex complications. This tailored approach allows clinics of all sizes to focus on diabetes care, enhancing both patient outcomes and clinic performance.

This flexible model ensures that every clinic, regardless of size, can effectively address diabetes-related health challenges.

Strategic Focus

Even if a clinic cannot implement the full range of assessments, prioritizing key areas such as cardiovascular risk, peripheral arterial disease, or neuropathy can significantly enhance patient outcomes and clinic revenue. For example, a portable handheld AI fundus camera can diagnose diabetic retinopathy autonomously in under 60 seconds, eliminating the need for specialist referrals and closing crucial care gaps.

Revenue Model

Beyond improved patient care, this model also offers financial advantages. Clinics can generate substantial revenue by offering reimbursable tests under Medicare and Medicaid, ensuring these essential diagnostics are accessible to a broad patient population. Adopting this diabetes-centric philosophy leads to better care and stronger financial health for clinics.

Reimbursable by Medicare

Provider Bundles

Monitor Weight Loss & Hormone Therapy

Identify Risks Early 

Diabetes Testing Centers offers a range of comprehensive provider bundles tailored to the specific assessments and therapies for various medical specialties. Each bundle is designed to integrate seamlessly into existing workflows, ensuring that providers can offer targeted, effective care without disruption. This approach helps address the unique needs of patients with diabetes and related conditions, enhancing overall health outcomes.


Each bundle is crafted to seamlessly integrate into existing workflows, enabling providers to deliver targeted, effective care without interruption. This approach is tailored to meet the unique needs of patients managing diabetes and related conditions, which are often associated with significant morbidities and mortalities that can go unchecked. By incorporating comprehensive assessments and management tools across various medical specialties:

These efforts aim to identify and address these conditions early, leading to improved health outcomes and more efficient care delivery. This efficiency ensures that healthcare providers' time and resources are used effectively, enhancing the overall care experience.

Reduce Morbidities and Mortalities

Identify Cardiovascular Conditions Early

Long COVID Consequences

Cardiovascular disease is the leading cause of death for both men and women, posing a significant risk to diabetes patients, as heart attacks and strokes can be fatal and overshadow other diabetes-related conditions. The risk is even higher for individuals who have had COVID-19, as the virus can worsen cardiovascular issues, leading to complications like myocarditis and blood clots. Therefore, testing for cardiovascular risk factors is critical for early identification and management, which can help prevent life-threatening events such as heart attacks or strokes.

The CardioANS test, used by healthcare providers, evaluates a patient’s risk of mortality and major adverse cardiovascular events (MACE). This test graphs the heartbeat through systolic and diastolic cycles, tracking deviations in fingertip pressure caused by arterial stiffness. Using a proprietary algorithm, it accurately assesses arterial hardening by analyzing pulse wave variations against extensive research data.

For individuals with Long COVID, especially those with cardiovascular symptoms, primary care testing is crucial to determine if comprehensive imaging, such as echocardiograms, is necessary to evaluate the left ventricle. Monitoring the left ventricle is essential for developing interventions to address the virus’s lasting cardiovascular effects. Additionally, cognitive assessments should be performed to address "brain fog" in post-COVID patients.

Key Features


Left ventricular systolic dysfunction (LVSD) increases heart failure risk nearly 5x compared to normal function 

Kannel WB, Gordon T, and National Heart Institute (U.S.) (1968) The Framingham study: An epidemiological investigation of cardiovascular disease. Bethesda, MD., United States. Department of Health, Education, and Welfare, National Institutes of Health.

Schedule Below to Learn More

Go Beyond Blood Sugars